Ensign Peak Advisors Inc Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ensign Peak Advisors Inc reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 548,498 shares of the medical equipment provider's stock after selling 42,491 shares during the quarter. Ensign Peak Advisors Inc owned 0.15% of Intuitive Surgical worth $286,294,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ISRG. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical during the 4th quarter valued at about $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $82,517,000. Sycomore Asset Management lifted its position in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. lifted its position in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its position in shares of Intuitive Surgical by 73.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock worth $132,657,000 after purchasing an additional 114,149 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 188 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares in the company, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock worth $17,229,143 over the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 0.3%

Intuitive Surgical stock traded down $1.61 during trading hours on Friday, hitting $536.55. The stock had a trading volume of 925,598 shares, compared to its average volume of 1,631,682. Intuitive Surgical, Inc. has a 12-month low of $379.67 and a 12-month high of $616.00. The stock's 50-day moving average price is $500.93 and its 200-day moving average price is $535.03. The stock has a market capitalization of $192.31 billion, a P/E ratio of 83.71, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ISRG shares. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. UBS Group upped their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.